Bioxyne Limited (ASX:BXN)
0.0240
-0.0010 (-4.00%)
May 12, 2025, 4:10 PM AEST
Bioxyne Revenue
Bioxyne had revenue of 12.57M AUD in the half year ending December 31, 2024, with 398.65% growth. This brings the company's revenue in the last twelve months to 17.33M, up 167.45% year-over-year. In the fiscal year ending June 30, 2024, Bioxyne had annual revenue of 9.64M with 81.98% growth.
Revenue (ttm)
17.33M
Revenue Growth
+167.45%
P/S Ratio
3.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
54.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9.64M | 4.34M | 81.98% |
Jun 30, 2023 | 5.30M | 4.84M | 1,042.88% |
Jun 30, 2022 | 463.64K | -1.74M | -78.97% |
Jun 30, 2021 | 2.20M | -130.94K | -5.61% |
Jun 30, 2020 | 2.34M | 132.83K | 6.03% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Woolworths Group | 69.22B |
Coles Group | 44.52B |
Endeavour Group | 12.26B |
Treasury Wine Estates | 3.07B |
Metcash | 16.55B |
IDP Education | 933.51M |
Bega Cheese | 3.58B |
GrainCorp | 6.51B |
Bioxyne News
- 9 months ago - Bioxyne Delivers Australia's First Pharmaceutical Cannabis Gummies, Scales Up Manufacturing Capabilities - Benzinga